The patent contains claims that cover orally administrable compositions comprising Collegium’s proprietary micro-particle formulations. The formulations are designed to be more resistant to physical methods of tampering than
This patent will specifically protect Cytori’s Celution System-based devices and methods essential in novel cosmetic and reconstructive surgery procedures. According to Cytori, this is an important development for
The downsizing of the sales force started with Wyeth, which announced a lay off of 1,200 sales personnel in March, 2008. Later, in April, Johnson & Johnson announced
This Phase II study is designed to assess the safety, tolerability and efficacy of four transscleral iontophoretic doses of EGP-437, a proprietary formulation of a well studied corticosteroid,
In addition, Lev shareholders will receive the non-transferrable contractual right to two contingent payments of $0.50 each that could deliver up to an additional $174.6 million, or $1
As a condition for the exclusive negotiation rights, Dompe entered into a securities sale agreement with Dyax to purchase two million shares of Dyax common stock in a
Medicago has obtained a grant from the Quebec Ministry of Economic Development, Innovation and Export Trade to finance 40% of the study. The study will be conducted by
TraumaCad is expected to be integrated with other existing systems at Duke and will ultimately enable surgeons to have single-click access to TraumaCad. Zeev Glozman, founder and CEO
Neoprobe and Draximage hope to complete definitive agreements in the next 90 days. Under the terms of the proposed arrangements, unradiolabeled Lymphoseek kits will be marketed and sold
Under a named patient program (NPP), investigational drugs can be administered to patients who are suffering from serious illnesses until the drug is approved by the European Medicines
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.